These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 25524814)

  • 21. Acquired inflammatory demyelinating neuropathies.
    Ensrud ER; Krivickas LS
    Phys Med Rehabil Clin N Am; 2001 May; 12(2):321-34, ix. PubMed ID: 11345010
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Peripheral nerve hypertrophy in chronic inflammatory demyelinating polyradiculoneuropathy detected by ultrasonography.
    Imamura K; Tajiri Y; Kowa H; Nakashima K
    Intern Med; 2009; 48(7):581-2. PubMed ID: 19336966
    [No Abstract]   [Full Text] [Related]  

  • 23. Letter to the editor referring to "Peripheral nerve hypertrophy in chronic inflammatory demyelinating polyradiculoneuropathy detected by ultrasonography".
    Granata G; Pazzaglia C; Caliandro P; Martinoli C; Padua L
    Intern Med; 2009; 48(23):2049; author reply 2051. PubMed ID: 19952491
    [No Abstract]   [Full Text] [Related]  

  • 24. Guillain-Barre/CIDP-like neuropathy in two parkinsonian patients following intestinal levodopa/carbidopa treatment.
    Galazky I; Schoof J; Stallforth S; Kupsch A; Heinze HJ; Kluge C
    Parkinsonism Relat Disord; 2014 Jan; 20(1):125-7. PubMed ID: 24044946
    [No Abstract]   [Full Text] [Related]  

  • 25. Peripheral nerve proteins as potential autoantigens in acute and chronic inflammatory demyelinating polyneuropathies.
    Lim JP; Devaux J; Yuki N
    Autoimmun Rev; 2014 Oct; 13(10):1070-8. PubMed ID: 25172243
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Destruction of paranodal architecture in inflammatory neuropathy with anti-contactin-1 autoantibodies.
    Doppler K; Appeltshauser L; Wilhelmi K; Villmann C; Dib-Hajj SD; Waxman SG; Mäurer M; Weishaupt A; Sommer C
    J Neurol Neurosurg Psychiatry; 2015 Jul; 86(7):720-8. PubMed ID: 25694474
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical guideline review: Guillain-barre syndrome and chronic inflammatory demyelinating polyneuropathy].
    Mori K; Hattori N; Sobue G
    Nihon Naika Gakkai Zasshi; 2002 Aug; 91(8):2443-57. PubMed ID: 12373856
    [No Abstract]   [Full Text] [Related]  

  • 28. [Recent aspects of acute and chronic inflammatory polyneuropathies: Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy].
    Pascual-Pascual SI
    Rev Neurol; 2002 Aug 1-15; 35(3):269-76. PubMed ID: 12235589
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inflammatory neuropathies.
    Whitesell J
    Semin Neurol; 2010 Sep; 30(4):356-64. PubMed ID: 20941668
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Acute and chronic inflammatory neuropathies--diagnosis].
    Köller H; Kieseier BC; Jander S; Hartung HP
    Dtsch Med Wochenschr; 2003 Jun; 128(24):1357-60. PubMed ID: 12802746
    [No Abstract]   [Full Text] [Related]  

  • 31. Multifocal motor sensory demyelinating neuropathy: inflammatory demyelinating polyradiculoneuropathy.
    Oh SJ; LaGanke C; Powers R; Wolfe GI; Quinton RA; Burns DK
    Neurology; 2005 Nov; 65(10):1639-42. PubMed ID: 16301495
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Severe Guillain-Barre syndrome following initial infection with varicella in a young adult].
    Barriga FJ; Martín M; Castilla V; Dobato JL; Pareja JA; Vela L
    Rev Neurol; 2000 Aug 1-15; 31(3):297-300. PubMed ID: 10996931
    [No Abstract]   [Full Text] [Related]  

  • 33. Nerve ultrasonography in early Guillain-Barré syndrome: a need for large prospective studies.
    Berciano J; Gallardo E; Sedano MJ; Orizaola P; Sánchez-Juan P; González-Suárez A; García A; Terán-Villagrá N; Ruiz-Soto M; Landeras-Álvaro R; Berciano MT; Lafarga M
    J Peripher Nerv Syst; 2014 Dec; 19(4):344. PubMed ID: 25661052
    [No Abstract]   [Full Text] [Related]  

  • 34. Antibodies to LM1 and LM1-containing ganglioside complexes in Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy.
    Kuwahara M; Suzuki S; Takada K; Kusunoki S
    J Neuroimmunol; 2011 Oct; 239(1-2):87-90. PubMed ID: 21914557
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The diagnostic value of midbrain hyperechogenicity in ALS is limited for discriminating key ALS differential diagnoses.
    Hermann A; Reuner U; Schaefer J; Fathinia P; Leimert T; Kassubek J; Leimert M; Ludolph AC; Storch A
    BMC Neurol; 2015 Mar; 15():33. PubMed ID: 25879789
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Acute and chronic inflammatory neuropathies--therapy].
    Köller H; Kieseier BC; Jander S; Hartung HP
    Dtsch Med Wochenschr; 2003 Jun; 128(25-26):1405-7. PubMed ID: 12813675
    [No Abstract]   [Full Text] [Related]  

  • 37. Patients with chronic inflammatory demyelinating polyneuropathy initially diagnosed as Guillain-Barré syndrome.
    Odaka M; Yuki N; Hirata K
    J Neurol; 2003 Aug; 250(8):913-6. PubMed ID: 12928908
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Recurrent Guillain-Barré syndrome after surgery].
    Olivier N; Laribi H; Pages M; Camu W; Juntas Morales R
    Rev Neurol (Paris); 2010; 166(6-7):644-7. PubMed ID: 20070996
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reply to the letter: "The diagnostic value of MRI in pediatric chronic inflammatory demyelinating polyradiculoneuropathy".
    Abe Y; Terashima H; Hoshino H; Sassa K; Sakai T; Ohtake A; Kubota M; Yamanouchi H
    Brain Dev; 2016 Jan; 38(1):174. PubMed ID: 25963376
    [No Abstract]   [Full Text] [Related]  

  • 40. Novel immunotherapeutic strategies in chronic inflammatory demyelinating polyneuropathy.
    Mathis S; Vallat JM; Magy L
    Immunotherapy; 2016 Feb; 8(2):165-78. PubMed ID: 26809024
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.